PRN: Pharma IQ Publishes Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012
Pharma IQ Publishes Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012
LONDON, February 10, 2012 /PRNewswire/ --
Industry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.com
In the wake of high profile staff cuts at multinational global pharmaceutical and biotech companies, leading industry network Pharma IQ conducted a large scale study into job stability and future prospects for the industry in 2012.
The results of the study have now been published in a 13 page special report entitled "Big Pharma Global Recession Report".
Among the finding of the study which surveyed hundreds of professionals is the fact that 44.4% of those surveyed are concerned their role being made redundant in the next twelve months.
Other outcomes from the report include increasing outsourcing and offshoring, renewed scrutiny on sales ROI and net reaction in R&D spend.
Pharma-IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community.
IQPC Ltd - IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape.